1. Retracted: MicroRNA‐373 promotes the development of endometrial cancer by targeting LATS2 and activating the Wnt/β‐Catenin pathway
   Yan Li et al, 2019, Journal of Cellular Biochemistry CrossRef
2. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis
   Raquel Nogueras Pérez et al, 2023, International Journal of Molecular Sciences CrossRef
3. miR-373 suppresses gastric cancer metastasis by downregulating vimentin
   Yinghong Shi et al, 2017, Molecular Medicine Reports CrossRef
4. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
   Peng Chen et al, 2019, Bioscience Reports CrossRef
5. LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p
   Zhuo Ye et al, 2019, Cancer Cell International CrossRef
6. Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes
   Noha M. Bakr et al, 2021, Journal of Genetic Engineering and Biotechnology CrossRef
7. DLK2 Acts as a Potential Prognostic Biomarker for Clear Cell Renal Cell Carcinoma Based on Bioinformatics Analysis
   Man-Gang Lee et al, 2022, Genes CrossRef